SCHEMBL3859904

SCHEMBL3859904

Cc1cccc(-c2ccccc2CO)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 3/20 0.59
CD274 Q9NZQ7 3/20 0.59
FFAR1 O14842 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
HTR7 P34969 1/20 0.48
BAZ2B Q9UIF8 1/20 0.44
BAZ2A Q9UIF9 1/20 0.44
PDK2 Q15119 1/20 0.44
CNR2 P34972 2/20 0.43
CNR1 P21554 1/20 0.43
PTGER1 P34995 1/20 0.42
PTGER4 P35408 1/20 0.42
PTGER3 P43115 1/20 0.42
PTGER2 P43116 1/20 0.42
DPP4 P27487 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30859521 1.00 PDCD1 (0.59) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL11673570 0.83 FFAR1 (0.49) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL12434742 0.81 FFAR1 (0.45) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL3787422 0.81 DPP4 (0.62) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL812762 0.80 PDCD1 (0.57) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL6346721 0.80 FFAR1 (0.53) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL26545737 0.80 FFAR1 (0.47) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL2922149 0.80 RAB9A (0.52) PDCD1CD274HTR7PDK2CNR2
SCHEMBL9890647 0.80 PTGER1 (0.57) PDCD1CD274FFAR1FFAR4HTR7
SCHEMBL28414965 0.80 ACHE (0.55) PDK2CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024057020-A1 ANTI-VIRAL COMPOUNDS Infex Therapeutics Limited (GB) 2024-03-21 WO disclosed
US-8440702-B2 1,3-oxazolidin -2-one derivatives useful as CETP inhibitors MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
US-20110178059-A1 1,3-OXAZOLIDIN -2-ONE DERIVATIVES USEFUL AS CETP INHIBITORS MERCK SHARP & DOHME CORP. (US) 2011-07-21 US disclosed
US-7915271-B2 1,3-oxazolidin-2-one derivatives useful as CETP inhibitors MERCK SHARP & DOHME CORP. (US) 2011-03-29 US disclosed
US-7592487-B2 Chiral tertiary aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2009-09-22 US disclosed
US-20090137548-A1 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors MERCK SHARP & DOHME LLC 2009-05-28 US disclosed
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178059-A1 1,3-OXAZOLIDIN -2-ONE DERIVATIVES USEFUL AS CETP INHIBITORS CETP, MTTP, APOB PDCD1 2478/4885CD274 4162/4885FFAR1 1223/4885
US-20080045757-A1 Chiral Tertiary Aminoalkylnaphthols ALDH7A1, ADH5, ALDH1A1 PDCD1 2615/4885CD274 1885/4885FFAR1 1269/4885
US-20090137548-A1 1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors CETP, MTTP, APOB PDCD1 2478/4885CD274 4162/4885FFAR1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.